Ovid Therapeutics Inc - OVID EV/Sales multiplikatori

Ovid Therapeutics Inc. (OVID) kompaniyasining rasmiy ramzlari

Ovid Therapeutics Inc. (OVID) noyob miya patologiyalari va epilepsiya uchun terapiyalarga e'tibor qaratgan holda global neyromeditsina bozoriga kirib bormoqda. EV/Sales tendentsiyasi ushbu salohiyatni tasdiqlaydi, bunda 218882.76 parametrning joriy holatini aks ettiradi. Muvaffaqiyat klinik bosqichlardan o'tish va grantlarni ta'minlashga bog'liq. Joriy sotuvlarning yo'qligi narx belgilash imkoniyatini yo'qqa chiqaradi; biroq, kelajakdagi patentlar FDA tasdig'idan so'ng monopoliyani ta'minlaydi.

OVID - Ovid Rx EV/Sales multiplikatori 23.11.2025 - 20.11.2026 oraligʻida

Ovid Rx (OVID) moliyaviy va bozor koʻrsatkichlari kesimi

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- emitentning bozor qiymati haqida ma'lumotlar:
- pul qoldiqlari va pul oqimlari ma'lumotlari:
Kompaniyaning fundamental baholanishi:OVID (Ovid Therapeutics Inc)
Ovid Therapeutics Inc seriyali mahsuloti

Ovid Therapeutics Inc. epileptologiya sohasidagi yuqori ilmiy nufuzdan foydalangan holda, kam uchraydigan nevrologik patologiyalarni davolash uchun innovatsion maqsadli molekulalarni ishlab chiqishga ixtisoslashgan. EV-to-revenue koeffitsiyentini tahlil qilish orqali investor korxona qiymatini keltirilgan daromadga nisbatan baholaydi, bunda yuqoriga yo'nalgan tendentsiya kompaniyaning istiqbollariga nisbatan bozor optimizmini aks ettiradi, keskin cho'qqilar esa aktivlarning haddan tashqari qimmat baholanishi xavfidan signal beradi.

Ovid Therapeutics Inc. raqobatchilari tahlili

BIIB (Biogen Inc.) - Kompaniya qiymati va daromad nisbati|NBIX: EV/Sales multiplikatori|RGC (Regencell Bioscience Holdings Limited) - Korxona qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati Axsome Therapeutics Inc|ACAD: Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori XENE|EV/Sales multiplikatori vikingtherapeutics.com (VKTX)|Korxona qiymatining daromadga nisbati Supernus SUPN|Biznes qiymatining daromadga nisbati CPRX|denalitherapeutics.com - EV/Sales multiplikatori|Kompaniya umumiy qiymatining daromadga nisbati Harmony Pharma HRMY|BHVN: EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - EV/Sales multiplikatori|Kompaniya qiymati va daromad nisbati PRAX (Praxis Medicines)|Korxona qiymatining daromadga nisbati Anavex Life Sciences (AVXL)|Korxona qiymatining daromadga nisbati CBLL (CeriBell EEG)|EV/Sales multiplikatori PRTA (Prothena Corp)|alector.com (ALEC) - Korxona qiymati/daromad multiplikatori|ANNX: Kompaniya qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori Omeros|NGNE: EV/Sales multiplikatori|Kompaniya qiymatining daromadga nisbati AC Immune|Kompaniya qiymatining daromadga nisbati VYGR|Kompaniya qiymati va daromad nisbati NMRA (neumoratx.com)|Kompaniya qiymatining daromadga nisbati SCLX (Scilex Holding Company, Inc.)|Korxona qiymatining daromadga nisbati TVGN (Tevogen Bio)|Korxona qiymatining daromadga nisbati Alpha Cognition ACOG|CGTX - Kompaniya qiymatining daromadga nisbati|IKT - Korxona qiymatining daromadga nisbati|SAVA: Korxona qiymatining daromadga nisbati|Assertio Therapeutics (ASRT) - Korxona qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori Coya Therapeutics Inc (COYA)|Korxona qiymatining daromadga nisbati Vistagen|Acumen Pharmaceuticals, Inc (ABOS) - Kompaniya umumiy qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati CervoMed, Inc. (CRVO)|ATHE - Korxona qiymati/daromad multiplikatori|EV/Sales multiplikatori CLNN (Clene Inc.)|Kompaniya umumiy qiymatining daromadga nisbati PepGen Inc. (PEPG)|JUNS - Korxona qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori Relmada Corp|ANVS (Annovis Bio, Inc.) - Kompaniya qiymatining daromadga nisbati|Grace Tx (GRCE) - EV/Sales multiplikatori|Kompaniya qiymatining daromadga nisbati AIFF|EV/Sales multiplikatori anewmeds.com|Korxona qiymatining daromadga nisbati NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Biznes qiymatining daromadga nisbati|MetaVia - Kompaniya qiymatining daromadga nisbati|NRXS: Kompaniya qiymati va daromad nisbati|Helius Medical Technologies, Inc. - EV/Sales multiplikatori|PASG: Korxona qiymatining daromadga nisbati|Neuphoria (NEUP) - Korxona qiymatining daromadga nisbati|Minerva Neurosciences - Biznes qiymatining daromadga nisbati|ATHA (Athira Pharma, Inc.) - EV/Sales multiplikatori|Korxona qiymati/daromad multiplikatori addextherapeutics.com ADXN|Kompaniya qiymatining daromadga nisbati ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori PTIX (Protagenic)|EV/Sales multiplikatori pasitheaclinics.com KTTA|CRGT - Korxona qiymatining daromadga nisbati|Biznes qiymatining daromadga nisbati ATXI (Avenue Therapeutics)|BCLI: EV/Sales multiplikatori|Cara Therapeutics - Biznes qiymatining daromadga nisbati|Korxona qiymatining daromadga nisbati Chromocell Therapeutics Corporation|EV/Sales multiplikatori Eliem Therapeutics Inc.|Korxona qiymatining daromadga nisbati Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Biznes qiymatining daromadga nisbati|EV/Sales multiplikatori MRNS (marinuspharma.com)|NKGN: Kompaniya qiymati va daromad nisbati|NRBO - Korxona qiymatining daromadga nisbati|SAGE - EV/Sales multiplikatori|Synaptogenix (SNPX) - Korxona qiymatining daromadga nisbati|Korxona qiymati/daromad multiplikatori Trevena (TRVN)|Kompaniya qiymatining daromadga nisbati VIGL|Kompaniya qiymati va daromad nisbati WENA (Anew Medical)|EV/Sales multiplikatori CERE